logo-loader
RNS
Solgenics Ltd

Solgenics Limited - Director/PDMR Shareholding

RNS Number : 3115Z
Solgenics Limited
12 May 2023
 

News Release

 

PDMR Dealing

 

 

12 May 2023: Solgenics Limited (the "Company") announces it has been notified that on 10 May 2023, Scott Fletcher, Non-Executive Director, purchased an aggregate of 3,500,000 ordinary shares of no par value in the Company ("Shares").

Scott Fletcher's purchases were made in compliance with the Company's share dealing policy, increasing his beneficial interest in Ordinary Shares in the Company to 167,667,036 Ordinary Shares, representing 29.60 per cent. of the Company's issued share capital.

Articles of Association

Under Article 32 of the Company's Articles of Association, where a person or persons acting in concert acquire 30% or more of the Company's issued share capital, the Board may, but is not obliged to require such persons to extend the offer to all shareholders. 

Further to the announcement on 16 January 2023 in connection with the loan conversion, whilst the Directors do not believe Hanno Pengilly, Seritza Limited, Mike Haworth and Scott Fletcher to be acting in concert, for the purposes of Article 32, Aman Sachdeva, as the independent director has agreed that it is in the best interest of the Company following the Company's announcement of its intention to delist, not to restrict any of them from acquiring further shares given that certain shareholders may wish to sell their shares ahead of the potential delisting.  In light of the current circumstances, Aman Sachdeva, as the independent director, will not require them to extend an offer to all shareholders under Article 32  where any of Seritza Limited, Mike Haworth or Scott Fletcher (with their connected parties) individually own or control 30% or more of the issued share capital provided that in aggregate they do not own or control 50% or more of the issued share capital.

This limit will be reassessed in light of the then current circumstances in the event that any of Seritza Limited, Mike Haworth or Scott Fletcher (with their connected parties) in aggregate intend to make further acquisitions such that they would own or control 50% or more of the issued share capital. 

Enquiries

For further information please visit www.solgenics.com or contact:

Solgenics:

Hanno Pengilly

+27 (0) 71 362 3566

Liberum Capital Limited:
NOMAD & Joint Broker

 

Scott Mathieson, Edward Thomas, Kane Collings

+44 (0) 20 3100 2000

Novum Securities Limited

Joint Broker

Colin Rowbury

+44 (0) 20 7399 9427

 

Pimlico Advisory Ltd

Investor Relations

Elizabeth Johnson

+44 (0) 777 56 55 927

 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018. Upon publication of this Announcement and such information is now considered to be in the public domain. The person who arranged for the release of this announcement on behalf of the Company was Hanno Pengilly, CEO.

About Solgenics

Solgenics is an African renewable energy development company focused on the development of a 300MW solar PV plus BESS renewable energy in the Tete Province in northern Mozambique (the "Tete Solar Project").

It is the intention that the Tete Solar Project will connect to the Mozambique grid with target power offtakers in Mozambique and the Southern African Power Pool ("SAPP").

The Tete Solar Project takes full advantage of Mozambique's leading sustainable energy resources and is fully aligned with Government's objective to become a champion for energy transition impacting all Southern Africa.

On 3 May 2023, Solgenics announced that it will shortly be posting a circular to shareholders (in connection with a proposal for the cancellation of admission of the ordinary shares of no par value in the Company ("Ordinary Shares") to trading on AIM (the "Cancellation"), pursuant to Rule 41 of the AIM Rules for Companies. Accordingly, if the resolution to approve the cancellation is approved by shareholders, the last day of dealings in the Ordinary Shares on AIM is expected to be 6 June 2023, and the Cancellation is expected to become effective at 7.00 a.m. on 7 June 2023.

The notification below is made in accordance with the requirements of the MAR.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

 1

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

Scott Fletcher

 

2

Reason for the notification

 

a)

Position/status

 

Non-Executive Director

b)

 

Initial notification /Amendment

Initial notification

 

 

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

Solgenics Limited

 

b)

LEI

2138003W7PP9STE9J18

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of no par value 

 

 

 

 

VGG640631039

b)

Nature of the transaction

On-market purchase of Ordinary Shares

 

 

 

 

c)

Price(s) and volume(s)

 

Price(s) GBP

Volume(s)

1.   0026

1.   3,500,000

 

 

d)

Aggregated information

- Aggregated volume

- Price

 

 

3,500,000

 

0.0026 GBP

 

 

e)

Date of the transaction

10 May 2023

 

 

f)

Place of the transaction

London Stock Exchange, AIM

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHSFDFLEEDSEEI
NO INVESTMENT ADVICE

Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.

Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.

This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.

In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.

The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.

Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

FOR OUR FULL DISCLAIMER CLICK HERE

Ncondezi Energy provides fresh numbers for Mozambique solar project

Ncondezi Energy Ltd (AIM:NCCL, OTC:NCDZF) CEO Hanno Pengilly gives Proactive more detail about the financial potential of its planned solar and battery energy storage project in the Tete Province of Mozambique. He says that the company ultimately intends for it to become 300MW project, but...

on 11/22/2022

5 min read